Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.44 USD | +7.96% | +6.55% | +35.56% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 60.54M |
---|---|---|---|---|---|
Net income 2024 * | -49M | Net income 2025 * | -74M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.82
x | P/E ratio 2025 * |
-2.71
x | Employees | 20 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.57% |
Latest transcript on Eledon Pharmaceuticals, Inc.
1 day | +7.96% | ||
1 week | +6.55% | ||
Current month | +2.09% | ||
1 month | +41.04% | ||
3 months | +44.38% | ||
6 months | +101.65% | ||
Current year | +35.56% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 20-04-30 | |
Paul Little
DFI | Director of Finance/CFO | 60 | 21-03-14 |
Steven N. Perrin
PSD | President | 59 | 20-09-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Keith Katkin
CHM | Chairman | 52 | 17-04-30 |
Walter C. Ogier
BRD | Director/Board Member | 67 | 20-09-13 |
John S. McBride
BRD | Director/Board Member | 72 | 17-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 2.44 | +7.96% | 405,517 |
24-05-07 | 2.26 | -7.38% | 2,532,836 |
24-05-06 | 2.44 | +1.24% | 92,932 |
24-05-03 | 2.41 | +4.78% | 178,489 |
24-05-02 | 2.3 | +0.44% | 118,903 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.56% | 60.54M | |
+2.93% | 108B | |
-0.87% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- ELDN Stock